Tricuspid and Bicuspid Valves Present More Coincidences Than Expected

There is more and more positive evidence that new-generation transcatheter valves, originally designed to treat tricuspid aortic valves, work perfectly fine on bicuspid aortic valves.

Más coincidencias de las esperadas entre válvulas bicúspides y tricúspides

A comparison of computerized tomography (CT) scans obtained before and after the procedure showed that the most commonly used devices appear to reshape the aortic annulus to the same degree in both standard patients and in patients with bicuspid valves.


Read also: Transcatheter Reduction or Surgery for Paravalvular Leak Repair?”


The BAVARD multicenter register, presented at PCR London Valves 2017, only looked at imaging results, but all patients included are being tracked in order to obtain information on endpoints such as paravalvular leak, stroke, bleeding, pacemaker implantations, etc.

 

In the current analysis, investigators reviewed pre- and post-implantation CT scans for 97 patients with bicuspid valve disease and compared them with 88 tricuspid aortic stenosis patients. Among these patients, 92% had type 1 bicuspid disease—the most common type seen among people of European descent. The devices used were those most commonly used in Europe (Sapien 3, Evolut R, and Lotus).

 

Measurements of the intercommissural distance were roughly similar between both patient groups, with intercommissural distance in bicuspid patients typically measured 4 mm above the level of the annulus. Annulus size was actually different between these groups, with a mean 23.6 mm for tricuspid patients and a mean 26.9 mm for bicuspid patients.


Read also: Multivessel Disease and Severe Carotid Stenosis: How to Proceed”.


The idea that bicuspid valves have a more elliptically shaped annulus was proven wrong in this work; the annulus shape is exactly the same, although the annulus for bicuspid patients is bigger.

 

Another assumption has been that transcatheter valves are typically implanted at a different height in bicuspid patients, but this was also proven wrong. Implantation depth was 3.4 mm in both patient groups.

 

Device sizing must be determined by the annular dimensions in tricuspid valves and by the intercommissural distance in bicuspid valves.

 

The study can conclude that the second-generation devices used work well in bicuspid patients (at least for type 1 bicuspid disease, which made up most of the cases in this study) and a dedicated device for this patient subgroup seems to be unnecessary.

 

Original title: Bicuspid Aortic Valve Anatomy and Relationship with Devices. The BAVARD Multicenter Registry.

Reference: Tchétché D et al. Presented at: PCR London Valves 2017. September 25, 2017. London, England.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...